BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 18382255)

  • 1. Biomarkers in acute cardiovascular disease.
    Howie-Esquivel J; White M
    J Cardiovasc Nurs; 2008; 23(2):124-31. PubMed ID: 18382255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Redefinition of myocardial infarction--relevance of biomarkers].
    Weber M; Hamm C
    Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of existing and novel cardiac biomarkers for cardioprotection.
    Gaze DC
    Curr Opin Investig Drugs; 2007 Sep; 8(9):711-7. PubMed ID: 17729182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of biochemical markers in diagnosis of myocardial infarction.
    Khan IA; Wattanasuwan N
    Int J Cardiol; 2005 Sep; 104(2):238-40. PubMed ID: 16168823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of cardiovascular damage and dysfunction--an overview.
    Collinson PO; Gaze DC
    Heart Lung Circ; 2007; 16 Suppl 3():S71-82. PubMed ID: 17618829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular biomarkers in the ICU.
    Noveanu M; Mebazaa A; Mueller C
    Curr Opin Crit Care; 2009 Oct; 15(5):377-83. PubMed ID: 19606027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of cardiovascular damage.
    Collinson PO; Gaze DC
    Med Princ Pract; 2007; 16(4):247-61. PubMed ID: 17541289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troponin assays for the diagnosis of myocardial infarction and acute coronary syndrome: where do we stand?
    Eisenman A
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):509-14. PubMed ID: 16918269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troponin: the biomarker of choice for the detection of cardiac injury.
    Babuin L; Jaffe AS
    CMAJ; 2005 Nov; 173(10):1191-202. PubMed ID: 16275971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical biomarkers of cardiac injury: cardiac troponins and natriuretic peptides.
    Apple FS
    Toxicol Pathol; 2006; 34(1):91-3. PubMed ID: 16507549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
    Palazzuoli A; Iovine F; Gallotta M; Nuti R
    Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of cardiac troponins (T or I) measurement in cardiology and various clinical settings].
    Berroëta C; Provenchère S; Mongredien A; Lasocki S; Benessiano J; Dehoux M; Philip I
    Ann Fr Anesth Reanim; 2006 Oct; 25(10):1053-63. PubMed ID: 16019183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Troponin elevation--differential diagnostic considerations and prognostic importance].
    Jensen JK; Mickley H
    Ugeskr Laeger; 2003 Apr; 165(15):1541-5. PubMed ID: 12715654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of biomarkers in the emergency department and chest pain unit.
    Jaffe AS
    Cardiol Clin; 2005 Nov; 23(4):453-65, vi. PubMed ID: 16278117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac biomarkers in chronic renal disease.
    Collinson PO; Gaze DC
    Scand J Clin Lab Invest Suppl; 2008; 241():104-8. PubMed ID: 18569976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.